Sasken Technologies Ltd (SASKEN) is currently trading at 1,755.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Sasken Technologies is a product engineering and digital transformation company providing chip-to-cognition R&D services across semiconductor design, embedded software, connected devices, and AI-enabled engineering for global customers in automotive, communications, industrials and smart devices, with an expanded portfolio following the Borqs acquisition and the launch of Sasken Silicon. Q1 FY2027 delivered consolidated revenue of ₹339 Crores, up 24% year-on-year, with order bookings of US$47 million TCV and ACV of about US$40 million; the quarter also added five new logos and grew the active customer base to 93, signalling broadened commercial traction beyond legacy accounts. Sasken is undergoing a strategic evolution into a full-stack Chip-to-Cognition partner, combining semiconductor capabilities, ODM product solutions via Borqs, and AI-native engineering; management emphasised conversion of recent wins, disciplined profitable growth, and investments in talent and facilities including a Hubballi incubation centre and Hyderabad CoE. Margins showed divergence: software services gross margin expanded 240 basis points to 30.6% driven by utilization improvements and scale, while product solutions margins moderated to 5.9% due to memory availability, component pricing and program mix; consolidated gross margin was 21.9% and EBITDA margin was 9.5% for the quarter. The company reported a strong cash and investment position of ₹356 Crores, a global headcount of 2,658 with 85% utilization and 9.8% attrition, and management emphasised AI, semiconductor design, and automotive connectivity as key vectors for medium-term revenue diversification and upward margin trajectory.

Over the past 52 weeks, Sasken Technologies Ltd has traded between a low of ₹993.05 and a high of ₹2,785.05. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Sasken Technologies Ltd has a market capitalization of approximately 2,714.42. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Sasken Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 37.62 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 2,714.42 Cr, Sasken Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Sasken Technologies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Sasken Technologies Ltd is 37.62. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The 38th AGM was held on July 31, 2026 at 10:00 am IST through Video Conferencing/Other Audio-Visual Means (VC/OAVM).

The company has scheduled the Q1 FY27 earnings call for Monday, August 3, 2026, at 04:00 PM IST.

The stock jumped after Sasken reported Q4 FY26 results showing revenue up 125.67% YoY to ₹334.02 crore and net profit up 144.70% YoY to ₹26.99 crore.

Sasken Technologies scheduled its board meeting for Friday, May 8, 2026, to consider audited standalone and consolidated financial statements for the quarter and year ended March 31, 2026.